BE-80-2100622

Trial medication for Crohn’s disease (CD) and Colitis Ulcerosa (CU)

18 - 55+
  • Male
February
< 7 days
10
€ 2300

Are you:

  • a healthy male
  • aged from 18 to 65 years (inclusive)
  • with a BMI from 18.5 to 29.9 kg/m²
  • non-smoker, ex-smoker or no more than max. 9 cigarettes, 2 cigars or 2 pipes per day 
  • not using daily medication

What does this trial involve?

SGS trial BE-80-2100622 investigates the treatment of Crohn’s disease (CD) and Colitis Ulcerosa (CU). During 5 months you will have the following appointments.

  • a screening 
  • 4-day (3-night) stay 
  • 10 short follow-up visits 
  • a final examination

Take part in this trial and

  • help us develop tomorrow's medicines
  • and receive a generous tax-free (in Belgium) payment of € 2300

View information leaflet

Any other questions?

Ask your question 

BE-80-2100622

Registration form

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Any other questions?

Ask your question